Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.

April 15, 2022

Recipharm Commissions Bengaluru Facility for Nonbacterial Beta-Lactam Tablet Manufacturing

January 28, 2026

Life Sciences Voice Top Five Newsletter- March 2023

March 11, 2023

Must Read

BioMarin’s BMN 401 Meets One Primary Goal but Misses Clinical Endpoint in Late-Stage ENPP1 Deficiency Trial

May 20, 2026

AstraZeneca receives approval for blood pressure medication

May 20, 2026

Regeneron’s Melanoma Drug Underperforms in Phase 3 Trial

May 20, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

BioMarin’s BMN 401 Meets One Primary Goal but Misses Clinical Endpoint in Late-Stage ENPP1 Deficiency Trial

Regeneron’s Melanoma Drug Underperforms in Phase 3 Trial

Alkermes Reports Positive Phase 3 Results for Lumryz in Idiopathic Hypersomnia

Good News For Enterprise As It Announces Phase 2 Cystic Fibrosis Victory

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Will AI Replace Traditional CRO Models in Clinical Research?

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

What Happens When AI Becomes a Scientific Co-Pilot?

Digital Twins in Healthcare: Hype, Reality, and Future Applications

Tag: AI Drug Discovery

Which AI Drug Discovery Companies Are Leading the Market in 2026?

Editor Picks

Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.

Recipharm Commissions Bengaluru Facility for Nonbacterial Beta-Lactam Tablet Manufacturing

Life Sciences Voice Top Five Newsletter- March 2023

Must Read

BioMarin’s BMN 401 Meets One Primary Goal but Misses Clinical Endpoint in Late-Stage ENPP1 Deficiency Trial

AstraZeneca receives approval for blood pressure medication

Regeneron’s Melanoma Drug Underperforms in Phase 3 Trial

Hot Topics

About Us

Follow Us